AZ pens three-year alliance with Cancer Research UK; later expands
AstraZeneca PLC has teamed up with Cancer Research Technology Ltd. under a three-year partnership to develop new oncology drugs.
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.